-
公开(公告)号:US6146630A
公开(公告)日:2000-11-14
申请号:US946838
申请日:1997-10-08
申请人: Kazuo Tsubota , Tsutomu Takeuchi
发明人: Kazuo Tsubota , Tsutomu Takeuchi
IPC分类号: A61K38/00 , A61K39/395 , A61P5/00 , A61P27/02 , A61P37/00 , A61P37/02 , A61P37/06 , A61P43/00 , C07K16/28
CPC分类号: C07K16/2839 , C07K16/28 , A61K2039/505
摘要: The present invention provides adhesion inhibitors for suppressing the adherence between E-cadherin of glandular cells and integrin of lymphocytes. Sjogren's syndrome comprises disorders wherein secretory glands such as lacrimal gland are destroyed by autoimmunity, and the adherence of CD8.sup.+ T cells to the surface of acinar cells is observed by the immunohistological analysis of lacrimal gland from patients. Integrin on the surface of T cells and E-cadherin on the surface of acinar cells play a major role in the mechanism of adhesion between these cells, while the adherence of T cells to acinar cells is reduced using anti-E-cadherin and anti-integrin antibodies. Sjogren's syndrome, such as autoimmune adenitis, can be treated using these antibodies.
摘要翻译: 本发明提供了抑制腺细胞的E-钙粘蛋白与淋巴细胞的整联蛋白之间粘附的粘合抑制剂。 Sj + E,cir o + EE gren综合征包括其中分泌腺如泪腺被自身免疫破坏的疾病,并且通过对患者的泪腺的免疫组织学分析观察到CD8 + T细胞对腺泡细胞表面的粘附。 在腺泡细胞表面的T细胞和E-钙粘蛋白表面的整合素在这些细胞之间的粘附机制中起主要作用,而使用抗E-钙粘蛋白和抗E-钙粘蛋白减少T细胞对腺泡细胞的粘附, 整合素抗体。 可以使用这些抗体治疗Sj + E,cir o + EE gren综合征,例如自身免疫性腺炎。